Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,359,736
in 11 filings, $2.4M under 10b5-1 plans

Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-23 NASH DAVID Director Grant or award +6,865 38,561
2022-04-27 NASH DAVID Director Grant or award +10,049 31,696
2021-03-23 NASH DAVID Director Grant or award +9,292 21,647
2020-04-10 NASH DAVID Director Grant or award +7,119 12,355
2019-05-24 NASH DAVID Director Purchase +1,445 $68.76 $99K 5,236
2019-03-28 NASH DAVID Director Grant or award +1,991 3,791
2019-03-28 NASH DAVID Director Grant or award · Stock Options +2,409 2,409
2018-06-06 NASH DAVID Director Grant or award +1,800 1,800
2018-06-06 NASH DAVID Director Grant or award · Stock Options +2,225 2,225

Page 1 of 1 · 9 trades